STRICTLY PRIVATE AND CONFIDENTIAL Dated 2nd June 2022 ZURA BIO LIMITED and OLIVER JACOB LEVYService Agreement • January 9th, 2023 • JATT Acquisition Corp • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 9th, 2023 Company Industry
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT NORMALLY TREATS AS PRIVATE AND CONFIDENTIAL. LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT DATED AS OF...License, Development and Commercialization Agreement • January 9th, 2023 • JATT Acquisition Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJanuary 9th, 2023 Company Industry JurisdictionThis License, Development and Commercialization Agreement (this “Agreement”), dated as of December 8, 2022 (the “Effective Date”), is made by and between Eli Lilly and Company, an Indiana corporation (“Lilly”), and Z33 Bio Inc., a Delaware corporation, having its principal place of business at MWE Corporate Services, LLC, 1007 N. Orange St., 10th Fl., Wilmington, Delaware 19801, USA (“Licensee”). Lilly and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Re: Additional Agreements relating to Series Seed Preferred Stock Investment AgreementAdditional Agreements Relating to Series Seed Preferred Stock Investment Agreement • January 9th, 2023 • JATT Acquisition Corp • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 9th, 2023 Company IndustryReference is made to (a) that certain Series Seed Preferred Stock Investment Agreement dated as of the date hereof (the “Agreement”), by and among Zura, Z33 Bio Inc., a Delaware corporation (the “Company”), and STONE PEACH PROPERTIES LLC, (company number 170448260) with a principal address at 1295 E Rock Springs Rd, Unit 308, Atlanta, GA, 30306, USA (“Founder Entity”), and (b) to the extent executed at any point in the future, that certain letter agreement regarding Additional Agreements relating to Series Seed Preferred Stock Investment Agreement (the “Lilly Letter Agreement”) by and between the Company and Eli Lilly and Company (“Lilly”). Capitalized terms used and not otherwise defined herein have the meanings assigned to them in the Agreement.